OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128 | -36.0% | 40,485 | +4.8% | 0.00% | – |
| Q2 2023 | $200 | -1.0% | 38,639 | +0.9% | 0.00% | – |
| Q1 2023 | $202 | +71.2% | 38,295 | -8.5% | 0.00% | – |
| Q4 2022 | $118 | -99.9% | 41,861 | +35.5% | 0.00% | – |
| Q3 2022 | $129,000 | +24.0% | 30,889 | +19.2% | 0.00% | – |
| Q2 2022 | $104,000 | +6.1% | 25,908 | +31.2% | 0.00% | – |
| Q1 2022 | $98,000 | +6.5% | 19,741 | +48.9% | 0.00% | – |
| Q4 2021 | $92,000 | -73.4% | 13,260 | -61.6% | 0.00% | – |
| Q3 2021 | $346,000 | -29.5% | 34,560 | -0.3% | 0.00% | – |
| Q2 2021 | $491,000 | -9.1% | 34,660 | +5.3% | 0.00% | – |
| Q1 2021 | $540,000 | +0.6% | 32,901 | +26.9% | 0.00% | – |
| Q4 2020 | $537,000 | – | 25,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |